COURAGE trial (The Lancet / EASD 2026) shows trevogrumab preserves 72% of quadriceps muscle in semaglutide patients. Plus: NMN wins historic FDA court battle restoring supplement status. Taurine longevity myth debunked by Science.
COURAGE trial (The Lancet / EASD 2026) shows trevogrumab preserves 72% of quadriceps muscle in semaglutide patients. Plus: NMN wins historic FDA court battle restoring supplement status. Taurine longevity myth debunked by Science.
COURAGE trial (The Lancet / EASD 2026) shows trevogrumab preserves 72% of quadriceps muscle in semaglutide patients. Plus: NMN wins historic FDA court battle restoring supplement status. Taurine longevity myth debunked by Science.
Clinical Trial Dispatch • Phase 3 Data Multicenter Trial Confirms Targeted Botanical Incretin Complex Elevates Postprandial GLP-1 Kinetics Without Receptor […]